Compound Detail
CHEMBL5204302
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CCCC[C@H]1CN(c2cccc(OC(F)(F)F)c2)C(=O)CN1Cc1cncn1Cc1ccc(C#N)c(Oc2ccccc2)c1
Basic Information
| ChEMBL ID | CHEMBL5204302 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BSBDNDMSOGBDOF-MHZLTWQESA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
603.6
MW (Da)
6.90
ALogP
7
HBA
0
HBD
83.6
PSA (Ų)
0.19
QED
2
Ro5 Violations
11
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 6.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 6.82 | 6.82 | 150.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 150.0 | nM | 6.82 | Inhibition of Cryptococcus neoformans farnesyltransferase assessed as inhibition... | 36218371 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36218371 | 10.1021/acs.jmedchem.2c00902 | Unchecked | 1 |
| 36218371 | 10.1021/acs.jmedchem.2c00902 | Cryptococcus neoformans | 1 |
Data from ChEMBL 36 via Core Engine